Papers

There are several studies, representing a variety of indications and conditions, that examine the efficacy and impact of the Venowave. We encourage you to take some time to review the findings, all of which demonstrate that the Venowave does indeed have a scientifically proven impact.

Deep Vein Thrombosis (DVT)

The Efficacy of a New Stimulation Technology to Increase Venous Flow and Prevent Venous Stasis

M. Griffin A.N. Nicolaides D. Bond G. Geroulakos E. Kalodiki “The Efficacy of a New Stimulation Technology to Increase Venous Flow and Prevent Venous Stasis”European Journal of Vascular and Endovascular Surgery (2010) 40, 766-771

Download

Prevention of Deep Vein Thrombosis in Potential Neurosurgical Patients

Alexander G. G. Turpie, FRCP; Jack Hirsh, MD; Michael Gent, MS; Denise Julian, MS; Judith Johnson, RN “Prevention of Deep Vein Thrombosis in Potential Neurosurgical Patients”Archives of Internal Medicine March 1989;149(3):679-681. (Abstract)

Read More

Venous Thromboembolism (VTE)

Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high-risk neurosurgical patients

Patients undergoing neurosurgical procedures are at risk of venous thromboembolism (VTE), but often have contraindications for anticoagulant prophylaxis. This study examines the efficacy and tolerability of the Venowave, for the prevention of VTE in neurosurgical inpatients.

Download

Improving limb salvage in critical ischemia with intermittent pneumatic compression

Intermittent pneumatic compression (IPC) is an effective method of leg inflow enhancement in patients with peripheral arterial disease. This study evaluated the clinical efficacy of IPC in patients with chronic critical limb ischemia, tissue loss, and nonhealing wounds of the foot after limited foot surgery (toe or transmetatarsal amputation) on whom additional arterial revascularization had been exhausted.

Download

Post Thrombotic Syndrome (PTS)

Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). A randomized controlled trial

O’Donnell MJ, McRae S, Kahn SR, Julian JA, Kearon C, Mackinnon B, Magier D, Strulovich C, Lyons T, Robinson S, Hirsh J, Ginsberg JS. (March 2008). “Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS). A randomized controlled trial”. Thromb Haemost. 3 (623-9). PMID 18327413.

Read More

Evaluation of a venous-return assist device to treat severe post-thrombotic syndrome (VENOPTS)

Severe post-thrombotic syndrome (PTS) is responsible for considerable disability, reduced quality of life and increased health care costs. Current therapies are limited and often ineffective. This study performed a two-centre, randomized, cross-over controlled trial to evaluate Venowave, for the treatment of severe PTS.

Read More

Effects of a Novel Venous-Return Assist Device (“Venowave”) on Lower Limb Venous Flow in Patients with Post-Thrombotic Syndrome.

This study evaluated the Venowave’s effect on increasing peak venous flow in patients with PTS and/or chronic lymphedema.

Download

Blood Study. Venowave increased peak venous flow (PVF) in patients with post-thrombotic syndrome (PTS) and/or chronic lymphedema.

This study evaluated the Venowave’s effect on increasing peak venous flow in patients with PTS and/or chronic lymphedema.

Download

Wounds

Improving limb salvage in critical ischemia with intermittent pneumatic compression: A controlled study with 18 month follow up

Steven J. Kavros, DPM, Konstantinos T. Delis, MD, MS, PhD, FRCSI, EBSQvasc, Norman S. Turner, MD, Anthony E. Voll, RN, Davis A. Liedl, RN, Peter Gloviczki, MD, Thom W. Rooke, MD “Improving limb salvage in critical ischemia with intermittent pneumatic compression: A controlled study with 18 month follow up”Journal of Vascular Surgery Volume 47, Issue 3 , Pages 543-549, March 2008

Download

Venous ulcers are wounds that are thought to occur due to improper functioning of venous valves, usually of the legs. They are the major cause of chronic wounds, occurring in 70% to 90% of chronic wound cases. Venous Ulcers can be very painful and a costly problem. Current treatments are labour intense and painful.

Saringer Life Science Technologies Inc. has noted in many anecdotal case study reviews that 100% percent of patients with long standing chronic foot ulcers that would not respond to any existing treatment, the Venowave contributed to rapidly healing the wounds. Such a result has prompted Dr. Jack Hirsh, Chief Science Officer and professor emeritus in medicine at McMaster Univerisity, to plan and lead a full randomized clinical trial to commence in 2012.

Share Us!